Key Points
The World Health Organization (WHO) has updated its guidance on treatments for patients with COVID-19, providing latest, trustworthy advice on the management of the disease to help doctors make better decisions...
The guidelines include latest clinical trial evidence for existing and new COVID-19 therapies, and takes account of evidence relating to safety, prognosis, resources, access, and equity issues, and patients values and preferences, the WHO said...
It also recommends against the use of the antiviral drugs remdesivir and molnupiravir for patients with non-severe COVID-19 at moderate and low risk of hospital admission..
You might be interested in
WHO updates its guidance on treatments for COVID-19
03, Dec, 23WHO recommends the use of antiviral drug nirmatrelvir-ritonavir in patients with non-severe COVID-19 at high and moderate risk of hospital admission. The World Health Organization (WHO) has updated its guidance on treatments for patients with COVID-19, providing latest, trustworthy advice on the management of the disease to help doctors make better decisions.
Cough sound analysis assists in determining severity of Covid-19 patients
26, Sep, 23The study states that assessing the cough sounds can help in detecting the risk of severe pneumonia | Health